Cover Image

Impact of EMT in stage IIIB/IV NSCLC treated with erlotinib and bevacizumab when compared with cisplatin, gemcitabine and bevacizumab

Saved in:
Bibliographic Details
Main Authors: Villalobos Bollen, Matthias Americo (Author) , Czapiewski, Piotr (Author) , Reinmuth, Niels (Author) , Fischer, Jürgen (Author) , Andreas, Stefan (Author) , Kortsik, Cornelius (Author) , Serke, Monika (Author) , Wolf, Martin (Author) , Neuser, Petra (Author) , Reuss, Alexander (Author) , Schnabel, Philipp Albert (Author) , Thomas, Michael (Author)
Format: Article (Journal)
Language:English
Published: February 21, 2019
In: Oncology letters
Year: 2019, Volume: 17, Issue: 6, Pages: 4891-4900
ISSN:1792-1082
DOI:10.3892/ol.2019.10153
Online Access:Resolving-System, kostenfrei, Volltext: http://dx.doi.org/10.3892/ol.2019.10153
Verlag, Volltext: https://doi.org/10.3892/ol.2019.10153
Verlag, Volltext: http://www.spandidos-publications.com/10.3892/ol.2019.10153/abstract
Get full text
Author Notes:Matthias Villalobos, Piotr Czapiewski, Niels Reinmuth, Jürgen R. Fischer, Stefan Andreas, Cornelius Kortsik, Monika Serke, Martin Wolf, Petra Neuser, Alexander Reuss, Philipp A. Schnabel and Michael Thomas
Description
Item Description:Gesehen am 31.01.2020
Physical Description:Online Resource
ISSN:1792-1082
DOI:10.3892/ol.2019.10153

Similar Items